Cargando…
Clinical Impact of Next-generation Sequencing in Pediatric Neuro-Oncology Patients: A Single-institutional Experience
The implementation of next-generation sequencing (NGS) in pediatric neuro-oncology may impact diagnosis, prognosis, therapeutic strategies, clinical trial enrollment, and germline risk. We retrospectively analyzed 58 neuro-oncology patients (31 boys, 27 girls, average age 7.4 years) who underwent NG...
Autores principales: | Barsan, Valentin, Paul, Megan, Gorsi, Hamza, Malicki, Denise, Elster, Jennifer, Kuo, Dennis J, Crawford, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892579/ https://www.ncbi.nlm.nih.gov/pubmed/31827999 http://dx.doi.org/10.7759/cureus.6281 |
Ejemplares similares
-
Canadian Pediatric Neuro-Oncology Standards of Practice
por: Bennett, Julie, et al.
Publicado: (2020) -
Editorial: Developmental therapeutics in pediatric neuro-oncology
por: Makimoto, Atsushi, et al.
Publicado: (2023) -
Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience
por: Ji, Matthew S, et al.
Publicado: (2020) -
World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology
por: Sulman, Erik P., et al.
Publicado: (2021) -
Editorial: Methods in neuro-oncology and neurosurgical oncology
por: Zoli, Matteo, et al.
Publicado: (2023)